SAN DIEGO–(BUSINESS WIRE)–Robbins Geller Rudman & Dowd LLP announces that a securities class action lawsuit has been filed in the District of New Jersey on behalf of purchasers of Aurora Cannabis Inc. (NYSE:ACB) securities between September 11, 2019 and November 14, 2019 (the “Class Period”). The case is captioned Wilson v. Aurora Cannabis Inc., No.…
DetailsSAN DIEGO–(BUSINESS WIRE)–Robbins Geller Rudman & Dowd LLP announces that a securities class action lawsuit has been filed in the Southern District of New York on behalf of purchasers of HEXO Corp. (NYSE:HEXO) common stock between January 25, 2019 and November 15, 2019 (the “Class Period”). The case is captioned Perez v. HEXO Corp., No.…
DetailsNEW YORK–(BUSINESS WIRE)–Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of HEXO Corp. (NYSE: HEXO) between January 25, 2019 and November 15, 2019, inclusive (the “Class Period”) of the important January 27, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Hexo…
DetailsCHICAGO–(BUSINESS WIRE)–Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco Labs” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that its executive team will participate in the following conferences in December 2019: Investor Intelligence Conference – Cowen Master Class, Las Vegas, December 10th at 2 p.m. PST: Charlie Bachtell,…
DetailsNEW YORK–(BUSINESS WIRE)–RTW Retailwinds, Inc. [NYSE:RTW], an omni-channel specialty apparel retail platform for powerful celebrity and consumer brands, today announced results for the third quarter of fiscal year 2019 ended November 2, 2019. Gregory Scott, Chief Executive Office of RTW Retailwinds, said: “Overall, we were disappointed with our third quarter results as softness in our…
DetailsBENSALEM, Pa.–(BUSINESS WIRE)–Law Offices of Howard G. Smith reminds investors of the upcoming January 21, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Aurora Cannabis Inc. (“Aurora” or the “Company”) (NYSE: ACB) securities between September 11, 2019 and November 14, 2019, inclusive (the “Class…
DetailsDENVER–(BUSINESS WIRE)– #alzheimers–Medicine Man Technologies Acquisiton Target, MedPharm, to Launch a Landmark Randomized Clinical Trial Taking Aim at Treating Alzheimer’s with Cannabis
LOUISVILLE, Ky.–(BUSINESS WIRE)–Brown-Forman Corporation (NYSE:BFA) (NYSE:BFB) reported financial results for its second quarter and first half of fiscal 2020. For the second quarter, the company’s reported net sales1 were up 9% to $989 million (+6% on an underlying basis2) compared to the same prior-year period. In the quarter, reported operating income increased 6% to $352…
DetailsWOONSOCKET, R.I. & TORONTO–(BUSINESS WIRE)–Abacus Health Products, Inc. (CSE: ABCS, OTCQX: ABAHF) (“Abacus” or the “Company”) today announced that it has secured from key shareholders a voluntary extension to lock-up agreements representing approximately 8 million subordinate voting shares, including subordinate voting shares issuable upon conversion of locked-up proportionate voting shares. The agreements were originally entered…
DetailsTORONTO–(BUSINESS WIRE)–FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD Pharma” or the “Company”) announces that Edward Brennan, MD, President, BioSciences Division, will present an overview of the Company at the 12th Annual LD Micro Main Event Investor conference at 12:20 p.m. PT/3:20 p.m. ET on Wednesday, December 11, 2019 at the Luxe Sunset…
DetailsOTTAWA, Canada–(BUSINESS WIRE)–Eureka 93 Inc. (CSE: ERKA, “Eureka93”) announced today that the current Board of Directors, after having reviewed strategic alternatives, has recommended that the company enter into an initial restructuring phase by reversing certain components of share transfer agreements, and entering to a share cancellation agreement, subject to partial revocation of the cease trade…
DetailsTORONTO–(BUSINESS WIRE)–Terrace Global Inc. (“Terrace Global” or the “Company”) (TSXV:TRCE), a multi-country operator focused on the development and acquisitions of international cannabis assets, believes it is well-positioned to capitalize on this week’s announcement, by Brazil’s National Agency for Health Surveillance (“Anvisa”), approving the importation and sale of medical cannabis while, at the same time prohibiting…
Details